Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin
Clinical trial NCT03161132 · COMPLETED
Trial details
- NCT number
- NCT03161132
- Sponsor
- Grupo Español de Investigación en Cáncer de Ovario
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-13
- Primary completion
- 2020-02-07
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.